These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 834733)

  • 1. [State of glucocorticoid activity in patients with different histologic variants of Hodgkin's disease].
    Popov OV; Smiller RR
    Probl Gematol Pereliv Krovi; 1977 Jan; 22(1):11-5. PubMed ID: 834733
    [No Abstract]   [Full Text] [Related]  

  • 2. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
    Pinkus GS; Said JW
    Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histologic diagnosis of Hodgkin's disease.
    Butler JJ
    Semin Diagn Pathol; 1992 Nov; 9(4):252-6. PubMed ID: 1480847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N
    Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urinary excretion of 5-hydroxyindoleacetic acid in patients treated for Hodgkin's disease].
    Chocha A; Kuchciński R; Szklarska W; Urbaniak Z
    Wiad Lek; 1976 Oct; 29(20):1795-7. PubMed ID: 997501
    [No Abstract]   [Full Text] [Related]  

  • 6. High molecular weight transforming growth factor beta is excreted in the urine in active nodular sclerosing Hodgkin's disease.
    Newcom SR; Tagra KK
    Cancer Res; 1992 Dec; 52(24):6768-73. PubMed ID: 1458464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hodgkin's disease--a histologic problem].
    Lauritzen AF; Specht L; Nissen NI; Hou-Jensen K
    Ugeskr Laeger; 1989 Nov; 151(47):3138-40. PubMed ID: 2688235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microalbuminuria in Hodgkin's disease.
    Dilek I; Demir C; Ustün Y; Erkoç R
    Int J Clin Pract; 2005 Mar; 59(3):330-2. PubMed ID: 15857331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoids in the treatment of children with acute lymphoblastic leukemia and hodgkin's disease: a pilot study on the adverse psychological reactions and possible associations with neurobiological, endocrine, and genetic markers.
    Felder-Puig R; Scherzer C; Baumgartner M; Ortner M; Aschenbrenner C; Bieglmayer C; Voigtländer T; Panzer-Grümayer ER; Tissing WJ; Koper JW; Steinberger K; Nasel C; Gadner H; Topf R; Dworzak M
    Clin Cancer Res; 2007 Dec; 13(23):7093-100. PubMed ID: 18056188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine excretion of nucleosides in Hodgkin's disease treated by combined chemotherapy.
    Dienstbier Z; Buric L
    Strahlentherapie; 1975 Feb; 149(2):208-11. PubMed ID: 1135891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histopathologic diagnosis and subclassification of Hodgkin's disease.
    Anastasi J; Bitter MA; Vardiman JW
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):187-204. PubMed ID: 2663822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgE levels in Hodgkin's disease.
    Thomas MR; Steinberg P; Votaw ML; Bayne NK
    Ann Allergy; 1976 Dec; 37(6):416-9. PubMed ID: 999061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The relations between Hodgkin's and non-Hodgkin's lymphoma].
    Lennert K
    Arzneimittelforschung; 1987 Feb; 37(2A):255-9. PubMed ID: 3566873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin's disease variant of Richter's syndrome clonally related to chronic lymphocytic leukemia arises in ZAP-70 negative mutated CLL.
    Tzankov A; Fong D
    Med Hypotheses; 2006; 66(3):577-9. PubMed ID: 16223567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of O6-alkylguanine-DNA alkyltransferase activity in peripheral blood lymphocytes: relationship between this activity in lymphocytes and in lymphoblastoid lines from normal controls and from patients with Hodgkin's disease or non-Hodgkin's lymphoma.
    Sagher D; Karrison T; Schwartz JL; Larson RA; Strauss B
    Cancer Res; 1989 Oct; 49(19):5339-44. PubMed ID: 2548719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin's disease with coexistent Castleman-like histologic features. A report of three cases.
    Zarate-Osorno A; Medeiros LJ; Danon AD; Neiman RS
    Arch Pathol Lab Med; 1994 Mar; 118(3):270-4. PubMed ID: 8135630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
    Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES
    Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous Hodgkin's disease.
    Silverman CL; Strayer DS; Wasserman TH
    Arch Dermatol; 1982 Nov; 118(11):918-21. PubMed ID: 7138051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
    Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thymic Hodgkin's disease with cystic variants: a case report].
    Kamiya N; Yokoi K; Mori K; Tominaga K; Miyazawa N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Sep; 33(9):999-1002. PubMed ID: 8538097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.